Zobrazeno 1 - 7
of 7
pro vyhledávání: '"José Alberto García-Seco"'
Publikováno v:
AACE Clinical Case Reports, Vol 7, Iss 3, Pp 177-179 (2021)
Objective: Hybrid closed-loop (HCL) devices can achieve tight glycemic control but are rarely used in pregnancy, which remains an off-label indication. We present a case of a pregnant patient with type 1 diabetes mellitus (T1DM) who used the Medtroni
Externí odkaz:
https://doaj.org/article/5f4bc130e0c246a6b24c38a4bd5da9e6
Autor:
José Alberto García-Seco, Angela María Seco, Miriam Herrera-Moraleda, Jesús Moreno-Ferández, José Ramón Muñoz-Rodríguez
Publikováno v:
International Journal of Diabetes in Developing Countries. 41:259-265
To analyze the real-life outcomes of insulin pump therapy, as compared to multiple daily injection (MDI) treatment, in adult type 1 diabetes mellitus (T1DM) patients from a tertiary diabetes care hospital in a Mediterranean scenario. Observational cr
Autor:
P. Olvera, F. Gallego-Gamero, M.T. Herrera, Jesús Moreno-Fernández, José Alberto García-Seco, José Ramón Muñoz-Rodríguez, Pilar Isabel Beato-Víbora
Publikováno v:
Diabetes Research and Clinical Practice. 181:109093
Aim To analyse the real-life outcomes of two sensor-augmented pumps (SAP) with predictive low glucose suspend (PLGS) function, Medtronic Minimed 640G™ with SmartGuard (MM640G) and Tandem T Slim X2™ with Basal-IQ™ (TTSX2), in Type 1 Diabetes Mel
Autor:
Fernando García-Seco, Jesús Moreno-Fernández, Elena María Ortega Rodrigo, Angela Maria Seco Segura, José Alberto García-Seco, José Ramón Muñoz-Rodríguez
Publikováno v:
Primary care diabetes. 14(4)
Aim To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients. Materials and methods Observational retrospective study using data obtained from computerized cl
Autor:
Angela Maria Seco Segura, Fernando García-Seco, Jesús Moreno-Fernández, José Alberto García-Seco, Pedro Jesus Rozas Moreno, Miguel Aguirre Sánchez-Covisa
Publikováno v:
Primary care diabetes. 14(1)
Aim Liraglutide and lixisenatide improved glycemic control, weight and cardiovascular risk factors (CVRF) in type 2 diabetes mellitus (T2DM) patients. Our objective was to analyze clinical efficacy and safety differences in routine clinical practice.
Autor:
José Alberto García-Seco, Miguel Aguirre Sánchez-Covisa, María Concepción Lozano-Hernández, Carmen Ferreiro-Vicario, Jesús Moreno-Fernández, Fernando García-Seco, Ángela María Seco-Segura, Monserrat Lozano-Serrano, Pedro Antonio Muñoz-Cazallas
Publikováno v:
Enfermería Clínica. 23:96-102
Resumen Objetivo Valorar la calidad de vida ( CV ) y satisfaccion (SF) de los pacientes con diabetes mellitus tipo 1 (DM1) en terapia con infusion subcutanea continua de insulina (ISCI) comparado con los pacientes tratados con multidosis diarias de i
Autor:
Monserrat, Lozano-Serrano, José Alberto, García-Seco, Fernando, García-Seco, María Concepción, Lozano-Hernández, Ángela María, Seco-Segura, Jesús, Moreno-Fernández, Pedro Antonio, Muñoz-Cazallas, Carmen, Ferreiro-Vicario, Miguel Aguirre, Sánchez-Covisa
Publikováno v:
Enfermeria clinica. 23(3)
To assess the quality of life (QOL) and satisfaction (SF) in patients with type 1 diabetes mellitus (T1DM) treated with continuous subcutaneous insulin infusion (CSII) compared with multiple daily insulin injections (MDI).A descriptive study was cond